Nephrology Times
Advertisement
Kidney care provider Evergreen Nephrology has added David Young to its board of directors.
In March, a patient at the Cleveland Clinic became the first in the US to receive a robot-assisted dual kidney transplant.
Are kidneys from donors who had dialysis more likely to result in adverse outcomes for transplant recipients?
A gift from the Schattner Foundation will support the American Kidney Fund's disaster relief program and other programs.
In a phase 2 study, adding tivozanib to nivolumab did not show a benefit for renal cell carcinoma treatment.
The American Heart Association has launched a 4-year plan to improve awareness and treatment of CKM syndrome.
Could a lifestyle intervention intended for overweight or obese diabetes patients improve kidney function?
Researchers examined how cardiovascular health status differs between men and women with kidney failure.
Ardelyx is suing the HHS and CMS over their addition of oral phosphate-lowering drugs to a bundled payment system.
The FDA granted a patent to Unicycive Therapeutics for UNI-494, a drug to treat acute kidney injury (AKI).
The FDA approved Velphoro (sucroferric oxyhydroxide) for hyperphosphatemia in patients with CKD as young as age 9.
Why do patients drop out of peritoneal dialysis after switching from hemodialysis and how does it affect mortality?
DaVita has agreed to pay $34,487,390 to resolve allegations that it paid illegal kickbacks.
The Senate passed legislation to prevent the abuse of the patent system through "patent thickets" to stifle competition.
Anjay Rastogi, MD, PhD, spoke about findings from the ZORA study regarding the efficacy of SZC for hyperkalemia.
Dialysis Patient Citizens has launched a first-in-the-nation kidney disease training curriculum for community health workers.
Kidney care services provider Fresenius Medical Care has entered into five wind and solar power purchase agreements.
The House Appropriations Committee voted to reduce funding of the Department of Health and Human Services by 7% for 2025.
Few studies have focused on outcomes after developing kidney failure and starting kidney replacement therapy.
The American Kidney Fund introduced guidelines to help patients with chronic kidney disease manage and treat hyperkalemia.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.